D'Onofrio Matthew J has filed 8 insider transactions across 1 company since February 2023.
Most recent transaction: a transaction of 15509 shares of Evoke Pharma Inc ($EVOK) on December 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | U | Common Stock | 15509 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.61% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | D | Stock Option (Right to Buy) | 70000 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 2.74% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | D | Stock Option (Right to Buy) | 64840 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 2.54% |
| March 21, 2025 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | A | Common Stock | 1000 | $2.80 | 9,820.0000 | 1,905,072 | 11.34% | 0.05% |
| Feb. 28, 2025 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | A | Common Stock | 6849 | $3.65 | 8,820.0000 | 1,905,072 | 347.49% | 0.36% |
| Jan. 28, 2025 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 1,905,072 | 9999.99% | 3.67% |
| Aug. 7, 2024 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | Chief Executive Officer | A | Stock Option (Right to Buy) | 64840 | $0.00 | 64,840.0000 | 278,558 | 9999.99% | 23.28% |
| Feb. 8, 2023 | Evoke Pharma Inc | $EVOK | D'Onofrio Matthew J | President & Chief Op. Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |